436 filings
Page 8 of 22
6-K
GLPG
Galapagos NV
9 Nov 20
Galapagos reports Q3 2020 results
4:01pm
6-K
GLPG
Galapagos NV
6 Nov 20
Current report (foreign)
10:06am
6-K
GLPG
Galapagos NV
3 Nov 20
Current report (foreign)
6:00am
6-K
GLPG
Galapagos NV
27 Oct 20
Current report (foreign)
12:13pm
6-K
GLPG
Galapagos NV
15 Oct 20
Galapagos and Servier report topline results for ROCCELLA Phase 2 clinical trial with GLPG1972/S201086 in knee osteoarthritis patients
5:27pm
6-K
GLPG
Galapagos NV
13 Oct 20
Current report (foreign)
6:15am
S-8
GLPG
Galapagos NV
9 Oct 20
Registration of securities for employees
4:32pm
6-K
GLPG
Galapagos NV
30 Sep 20
Galapagos announces first dosing with Toledo compound GLPG3970 in psoriasis trial
6:00am
6-K
GLPG
Galapagos NV
28 Sep 20
Current report (foreign)
6:00am
6-K
GLPG
Galapagos NV
25 Sep 20
Jyseleca® (filgotinib) approved in Japan for rheumatoid arthritis
6:05am
6-K
GLPG
Galapagos NV
21 Sep 20
Current report (foreign)
6:00am
6-K
GLPG
Galapagos NV
11 Sep 20
Primary endpoint achieved with ziritaxestat in NOVESA trial in systemic sclerosis patients
6:05am
6-K
GLPG
Galapagos NV
26 Aug 20
Galapagos to present new insights in IPF and related clinical developments at the European Respiratory Society Congress
6:37am
6-K
GLPG
Galapagos NV
19 Aug 20
Current report (foreign)
6:00am
6-K
GLPG
Galapagos NV
13 Aug 20
Current report (foreign)
9:42am
6-K
GLPG
Galapagos NV
6 Aug 20
Galapagos reports solid H1 2020 progress
4:01pm
6-K
GLPG
Galapagos NV
24 Jul 20
Current report (foreign)
9:45am
6-K
GLPG
Galapagos NV
8 Jun 20
Current report (foreign)
6:00am
6-K
GLPG
Galapagos NV
4 Jun 20
Current report (foreign)
11:01am
6-K
GLPG
Galapagos NV
29 May 20
Current report (foreign)
6:00am